Acadia Pharmaceuticals Inc 10-K for FY2025
Acadia Pharmaceuticals Inc (ACAD)
10-K
2026-02-26
For: 2025-12-31
View Original
Added on
April 04, 2026
About this 10-K
Acadia Pharmaceuticals Inc filed this 10-K on February 26, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $1.07B
- up 11.9% from $957.8M a year earlier
- Net income
- $391M
- up 72.7% from net income of $226.45M a year earlier
- Diluted EPS
- $2.30
- up 69.1% from $1.36 a year earlier